Patients’ Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer

20206 citationsJournal Articlegold Open Access

Authors

Prunella Blinman · The University of Sydney

Andrew Martin · The University of Sydney

Michael Jefford · The University of Melbourne

David Goldstein · Prince of Wales Hospital

David Boadle · Royal Hobart Hospital

Michelle Frances Morris · Sunshine Coast University Hospital

Niall C. Tebbutt

Abstract

Preferences varied substantially, and the benefits many required to warrant an extra 3 months of adjuvant chemotherapy were larger than the benefits of an extra 3 months of chemotherapy calculated in the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) meta-analysis.

Topics & Keywords

Colorectal Cancer Surgical Treatments Gastric Cancer Management and Outcomes Colorectal and Anal Carcinomas

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JNCI Cancer Spectrum

Volume 5, Issue 1

DOI: 10.1093/jncics/pkaa107

Field-Weighted Citation Impact: 0.17